Last viewed: ABMD

Prices are updated after-hours

Medical specialties ABMD Nasdaq

ABIOMED, Inc.

ABMD | $381.02 0.06% 0.07%

|

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (758.37% volume)
Earnings Calendar: 2023-02-02
Market Cap: $ 17,180,642,928
http://www.abiomed.com
Sec Filling | Patents | 1536 employees

(US) ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

heart brands

add to watch list Paper trade email alert is off

Press-releases

Global Cardiac Assist Devices Market Research Report 2023: Market to Reach $6.23 billion by 2028 - Growing Patient Pool and New Product Launches Driving New Opportunities
Published: 2023-11-22 (Crawled : 16:00) - prnewswire.com
TFX | News | $208.57 0.57% 35K

|

Health Technology

| -4.12% | O: 0.9% H: 0.43% C: -0.13%
ABT | News | $107.24 1.87% 2M

|

Health Technology

| 4.9% | O: 1.05% H: 0.0% C: 0.0%
report cardiac reach research global growing market

Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium
Published: 2023-10-23 (Crawled : 13:30) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M

|

Health Technology

| -4.84% | O: 0.28% H: 0.0% C: 0.0%
symposium

Global Heart Failure Devices Market Analysis Report 2022-2023 & 2029: Vast Pipeline Products, Increase in Product Approvals, Availability of Alternative Products
Published: 2023-04-21 (Crawled : 10:00) - prnewswire.com
TFX | News | $208.57 0.57% 35K

|

Health Technology

| -22.39% | O: 0.5% H: 0.91% C: 0.13%
MDT | $79.49 0.38% 1.4M

|

Health Technology

| -5.28% | O: 0.89% H: 4.63% C: 1.78%
EW | News | $86.355 -0.11% 520K

|

Health Technology

| 1.78% | O: 0.61% H: 0.87% C: 0.34%
BSX | $67.31 -0.16% 2.1M

|

Health Technology

| 28.13% | O: 0.82% H: 0.3% C: -3.66%
ABT | News | $107.24 1.87% 2M

|

Health Technology

| -3.58% | O: 0.48% H: 1.12% C: 0.7%
LIVN | $52.505 -0.48% 58K

|

Health Technology

| 4.51% | O: 0.16% H: 0.72% C: 0.22%
CSII | $20.0 -0.05% 400K

|

Health Technology

| 0.15% | O: -0.05% H: 0.1% C: 0.1%
ATRC | $23.13 -1.11% 54K

|

Health Technology

| -44.84% | O: 0.76% H: 0.57% C: -0.59%
report pipeline global heart alternative market

Johnson & Johnson Completes Acquisition of Abiomed
Published: 2022-12-22 (Crawled : 18:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M

|

Health Technology

| -18.42% | O: -0.51% H: 0.42% C: 0.15%
acquisition

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
Published: 2022-12-21 (Crawled : 14:20) - biospace.com/
ABMD | $381.02 0.06% 0.07%

|

Health Technology

| 0.06% | O: -0.0% H: 0.13% C: 0.06%
fda heart trial

First Patients in the World Treated with Impella RP Flex with SmartAssist
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

|

Health Technology

| 1.09% | O: 0.08% H: 0.36% C: 0.27%

INVESTOR ALERT: The M&A Class Action Firm Continues Investigating the Merger - ABMD, AGFS, AKUS, AIMC
Published: 2022-11-17 (Crawled : 23:00) - prnewswire.com
RRX | $158.73 1.78% 140K

|

| 26.4% | O: 1.91% H: 1.25% C: 0.89%
JNJ | News | $146.39 0.45% 1.8M

|

Health Technology

| -16.23% | O: 1.12% H: 0.0% C: 0.0%
LLY | $731.1 -1.99% 1M

|

Health Technology

| 108.1% | O: 0.49% H: 0.58% C: -0.24%
aigc

INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of ABIOMED, Inc. - ABMD
Published: 2022-11-02 (Crawled : 03:00) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M

|

Health Technology

| -16.6% | O: -0.66% H: 0.0% C: 0.0%
ABMD | $381.02 0.06% 0.07%

|

Health Technology

| 0.49% | O: -0.38% H: 0.0% C: 0.0%

Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M

|

Health Technology

| -16.9% | O: -0.36% H: 0.0% C: 0.0%
ABMD | $381.02 0.06% 0.07%

|

Health Technology

| 48.85% | O: 48.12% H: 0.0% C: 0.0%
year

Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

|

Health Technology

| 47.65% | O: -0.81% H: 0.0% C: 0.0%
fda heart approval

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-22-013033	4	2022-12-28	2022-12-22	Sell	D	123370	0
0001415889-22-013031	4	2022-12-28	2022-12-22	Sell	D	3255	0

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

79%

21%

Top 10 Gainers

AGBA | News | $1.22 205.0% 86M

|

EGOX | $0.0606 68.33% 250M

|

NVFY | $3.45 63.51% 20M

|

Consumer Durables

ZCMD | $1.98 36.55% 27M

|

Commercial Services

CHRO | $1.66 35.51% 70K

|

INDO | $5.43 33.09% 10M

|

Energy Minerals

PAPL | $2.07 26.22% 550K

|

RWOD | $10.08 26.05% 5.6M

|

AULT | $0.304 25.57% 47M

|

HUSA 4 | $2.07 23.95% 2.1M

|

Energy Minerals

Last 48 Hours Insiders Buying

CLSD | $1.42 7.58% 100K

|

Health Technology

| 14:00
CDZI P 25000 | $2.275 1.11% 74K

|

| 14:00
ETST P 39000 | $0.068 43K

|

| 13:30
FNLC P 1275 | $22.47 1.4% 6.6K

|

| 12:30
ADMQ | $0.0532 480K

|

| 10:30
AXR P 2400 | $22.26 0.41% 180

|

| 21:00
QCRH P 118 | $56.105 1.25% 11K

|

| 18:01
VUZI P 7500 | $1.245 -1.19% 140K

|

Electronic Technology

| 18:00
RMCF | $3.5501 390

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar